Drug intelligence / Profile preview

Gingilacer

Development stage
Unknown
Lead developer
Italfarmaco
Modality
Small Molecules, Drug Delivery Systems
Administration
Topical, Dental
01

Overview

Gingilacer is an oral care product line developed for the prevention and management of gum problems, particularly gingival bleeding and gingivitis. It is available primarily as a toothpaste and mouthwash. The formulation contains active ingredients such as zinc chloride (astringent to reduce gum bleeding), triclosan (antibacterial agent), potassium glycyrrhizate (anti-inflammatory), cymenol (antimicrobial), sodium monofluorophosphate or fluoride ion (for enamel strengthening and anti-caries action). The mechanism of action involves inhibition of bacterial activity to reduce dental plaque formation—the main cause of gingivitis—while the astringent effect of zinc helps restore gum tissue integrity and reduce inflammation. The product is alcohol-free, suitable for daily use, does not irritate gums or stain teeth, and is indicated for people with delicate gums or those prone to periodontal disease[1][3][4][5][7].

Brand names
Gingilacer
Other names
Gingilacer ToothpasteGingilacer Mouthwash

Beyond the preview

Go deeper on Gingilacer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gingilacer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call